AKG supplement for brain health in older adults
This study tests whether a daily supplement called AKG (alpha-ketoglutarate) can support brain health and thinking skills as we age. You would take the supplement for a period of time while researchers monitor your memory and overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 55 years old
- Have normal or corrected vision and hearing (glasses or hearing aids are fine)
- Read and write in English
- Score at least 26 on a standard memory and thinking test (the Montreal Cognitive Assessment)
- Have been on the same medicines for at least 3 months
- Not have certain health conditions such as active brain disease, uncontrolled depression, or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a daily supplement made from a natural algae called astaxanthin can help keep your memory sharp as you age. It is for older adults who have mild forgetfulness but are otherwise healthy.
This trial tests a special supplement combination designed to support brain energy use in people with Alzheimer's. It aims to see if the supplement can help slow cognitive decline.
This clinical trial is testing whether a special dietary supplement called Axolt can help keep your memory and thinking sharp as you get older. It is for healthy adults 55 and older who live independently and have no major memory problems.
This trial tests if a combination medicine, KarXT plus KarX-EC, can help with thinking and memory problems in people with mild to moderate Alzheimer's disease. It aims to see if the treatment is safe and effective.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
Hear when a new Brain Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.